Key result
Recombinant TNF-alpha restores Coxsackievirus B3 myocarditis susceptibility in female mice by upregulating CD1d.
Why the study?
Female C57BL/6 mice are resistant to CVB3-induced myocarditis, correlating with reduced TNF-alpha expression, but the mechanism of this sex-specific protection is unclear.
TNF-alpha promotes myocarditis susceptibility in female mice infected with Coxsackievirus B3 by upregulating CD1d on hematopoietic cells.
Answers are grounded in this paper and cite their sources.
TNF-alpha drives sex-specific CVB3 myocarditis susceptibility in mice; leaves open relevance to human viral myocarditis.
Coxsackievirus B3 (CVB3) induces cardiac inflammation (myocarditis) in male but not female C57BL/6 mice. Protection of females correlates with reduced expression of TNF-alpha and IL-1beta at both the mRNA and protein levels in the heart. Treatment of females with 300 ng/mouse of recombinant TNF-alpha on days +1 and +3 relative to infection restores myocarditis susceptibility to levels approximating those of infected male mice, showing that TNF-alpha deficiency is central to disease resistance. Female mice express little CD1d on spleen lymphocytes or cardiac myocytes, while females treated with TNF-alpha show increased CD1d expression in both cell populations. TNF-alpha treatment of male or female CD1d knockout (CD1dKO) mice failed to restore myocarditis susceptibility, demonstrating that of the multiple potential TNF-alpha activities, its ability to upregulate this non-classical major histocompatibility complex antigen is its dominant function in myocarditis susceptibility. Bone marrow chimeric mice were produced between female C57BL/6 and C57BL/6 CD1dKO mice so that either hematopoietic or non-hematopoietic cells were CD1d deficient. TNF-alpha treatment of chimeric mice having wild-type (CD1d+) hematopoietic cells restored myocarditis susceptibility, while TNF-alpha treatment of chimeric mice having CD1dKO hematopoietic cells, but CD1d+ myocytes, failed to develop myocarditis, showing that CD1d expression in lymphoid cells controls disease susceptibility.
No takes yet. Share an insight, caveat, or question.
Sally A. Huber (2010) studied Coxsackievirus B3 (CVB3) induced myocarditis. Recombinant TNF-alpha vs. Untreated/vehicle (implied) or CD1dKO mice was evaluated on Myocarditis susceptibility. Treatment with recombinant TNF-alpha restored myocarditis susceptibility in female mice infected with Coxsackievirus B3 through the upregulation of CD1d on hematopoietic cells.
Synapse has enriched 10 related papers. Consider them for comparative context: